Press releases from Lee Biosolutions

Healthcare: Earlier Detection and Treatment of Chronic Kidney Disease
Sep 28, 2009
According to publish reports there are over 26 million adults who fall into high risk groups having some form of Chronic kidney disease. How a novel protein like Human Cystatin C antigen can help

Next Generation of Biomarkers From Lee Biosolutions
Sep 23, 2009
Lee Biosolutions is involved with the development and purification of the next generation of cardiovascular biomarkers that has the potential of not only improving but also the ability to better treat patients with chronic and acute heart failure.

Lee Biosolutions Ferritin Product Line Increased
Sep 23, 2009
Lee Biosolutions announces that they have had to increase their capacity for the production of ferritin protein to meet current worldwide diagnostic and clinical research requirements.

Cell Cultured Tested Recombinant Human Proteins From Lee Biosolutions, Inc
Sep 23, 2009
Lee Biosolutions is introducing a new generation of recombinant cell culture products specifically targeted to maximize cell culture performance while still safeguarding the integrity of cell line and cell media.

Lee Biosolutions Increases Capacity For Lipase Production
Nov 16, 2007
Lee Biosolutions has had to increase inventory levels for human lipase and porcine lipase due to higher worldwide demand.

Human Renin for clinical researchers available from Lee Biosolutions, Inc
Nov 14, 2007
Lee Biosolutions, Inc announces increased inventory levels for high purity native human renin and high purity recombinant human renin for Clinical researchers world wide due to increase demand.

Myeloperoxidase Demand increases worldwide for Lee Biosolutions, Inc
Nov 14, 2007
Lee Biosolution has been a prefered supplier for Myeloperoxidase, troponin, myoglobin, Lactate dehydrogenase isoenzymes and creatine kinase isoenzymes to the diagnostic market for decades. Increased worldwide demand has contributed to its success.

Lee Biosolutions Human Salivary Amylase production increased to meet worldwide demand
Nov 14, 2007
Lee Biosolutions’ extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements for IVD manufacturers and clinical researchers.

High Purity Human Ferritin Antigen and Polyclonal Antibodies from Lee Biosolutions
Nov 14, 2007
Lee Biosolutions, Inc. announces the increased production and availability of the highest purity affinity purified polyclonal Ferritin antibodies and native human ferritin antigens to the clinical research community and IVD manufacturers.

Lee Biosolution increases inventory for C-Reactive Protein due to worldwide demand
Nov 13, 2007
C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Lee Biosolutions is a preferred supplier for the clinical diagnostic market